Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis
N. Jewel Samadder(Mayo Clinic), Scott K. Kuwada(University of Utah)
Cited by 142
Related Papers
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017
|Journal of the National Comprehensive Cancer Network|2017|215
Eosinophilic oesophagitis in patients presenting with dysphagia – a prospective analysis
|Alimentary Pharmacology & Therapeutics|2008|199
NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 1.2021.
|PubMed|2021|156
Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines In Oncology
|Journal of the National Comprehensive Cancer Network|2024|91